1 completed, 1 terminated, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Edrecolomab: new trials by email Literature Review of Edrecolomab trials Research Report on Edrecolomab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C Fluourouracil, Leucovorin, MAb 17-1A - Rectal Cancer Dukes B, Dukes C | Phase 3 | Terminated | Austrian Breast & Colorectal Cancer Study Group | 700 | 1997-07-01 | 2006-04-03 |
| Edrecolomab in Treating Patients With Stage II Colon Cancer edrecolomab, laboratory biomarker analysis - Mucinous Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Colon | Phase 3 | Completed | National Cancer Institute (NCI) | 2100 | 1997-05-01 | 2026-06-01 |
| Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer edrecolomab, sargramostim - Colorectal Cancer | Phase 2 | Withdrawn | James Ahlgren | 1995-07-01 | 2017-07-13 |
Colonic Neoplasms (2) · Rectal Neoplasms (2) · Colorectal Neoplasms (1)
Austrian Breast & Colorectal Cancer Study Group (1) · James Ahlgren (1) · National Cancer Institute (NCI) (1)
United States (2) · Austria (1)
James D. Ahlgren, MD (1) · Raimund Jakesz, MD (1) · Thomas Colacchio (1)
U10CA031946 (1)